An Analysis of the Classification and Therapeutic Effects of Hepatitis C Patients in Shaanxi
10.3969/j.issn.1003-4706.2018.08.015
- VernacularTitle:陕西地区丙肝患者分型与疗效分析
- Author:
Wei-Feng GONG
1
;
Yang-Min ZHANG
;
Xiao-Bo GUO
;
Shan LI
Author Information
1. 西安交通大学附属西安市中心医院输血科
- Keywords:
Hepatitis C virus;
Genotypes;
An Analysis of therapeutic effects
- From:
Journal of Kunming Medical University
2018;39(8):64-68
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the genotypes of hepatitis C patients in three large hospitals in Shanxi Province, and to analyze the results of the classification. Methods Genotypes and related disease markers of253 cases of hepatitis C positive patients in a total of 437 cases were analyzed.Results There was a significant difference in the I content of each type of bile acid receptor and HCV gene content among all HCV Classification patients (P<0.05) while there was no significant difference in the therapeutic effects of pegylated interferon and Galebavirin in different subtypes of HCV (P>0.05). Conclusions Hepatitis C patients in Shanxi province are mainly type Ib and type II A, and there are significant differences in each type of gene content (P<0.05). The content of I of bile acid receptor is of great significance in the judgement and treatment of the disease.Type 3 b, type 3 a and type 6 a have higher cure rates and better recovery rates, while type1 b, type 1 a and type 2 a have lower cure rates and recovery rates.The use of oral drugs makes hepatitis C treatment better.